Managed entry: Difference between revisions
Editor iHTS (talk | contribs) No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
'''Note 1:''' Related terms include managed entry agreement, managed entry scheme, [[coverage with evidence development]], and managed access. | '''Note 1:''' Related terms include managed entry agreement, managed entry scheme, [[coverage with evidence development]], and managed access. | ||
== Reference == | |||
http://htaglossary.net/managed-entry | |||
Latest revision as of 13:42, 21 November 2023
23Klemp M, Frønsdal KB, Facey K. What principles should govern the use of managed entry agreements? Int J Technol Assess Health Care. 2011 Jan;27(1):77-83.
A conditional arrangement between manufacturer and payer that enables earlier reimbursement of a health technology to address uncertainty in its performance or to manage its utilization.
Note 1: Related terms include managed entry agreement, managed entry scheme, coverage with evidence development, and managed access.